E. Bekker-Milovanov

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Pembrolizumab is a monoclonal antibody against the programmed cell death 1 (PD-1) receptor, and is widely used for the treatment of various malignancies, most commonly malignant melanoma. Here we report the first documented and pathology proven case of Organizing Pneumonia complicating treatment with Pembrolizumab. This was a man who presented with a dense(More)
  • 1